Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR ...

Patients who are more likely to experience exacerbations based on myasthenia gravis features include those with greater baseline impairment, thymoma, or anti-muscle specific tyrosine kinase (MuSK ...

Across 5 research centers, investigators evaluated the impact of eculizumab on thymoma-associated myasthenia gravis, a severe disease subtype.

FOR many years it has been recognized that myasthenia gravis is associated, in a high percentage of cases, with structural abnormalities of the thymus.1 Many patients, especially the younger ones, ...

Treatment for myasthenia gravis includes medications such as pyridostigmine and immunosuppressants. Avoiding triggers may also help. Learn more here.

Current myasthenia gravis treatments and those under development could help treat the autoimmune disorder's symptoms, leading to partial or complete remission. Learn more.

About Myasthenia Gravis Myasthenia gravis (MG) is a chronic autoimmune disorder that causes disabling muscle weakness and fatigue. For most people with MG, the disease is characterized by the presence ...

Treatments for myasthenia gravis include medications to help control and prevent symptoms related to muscle weakness and therapies during a myasthenic crisis (when symptoms worsen). Surgical removal ...

The analysis represents an effort to use bioinformatics to find potential new therapeutic targets for myasthenia gravis (MG). A new genetic analysis of patients with thymoma-associated myasthenia ...

HIF-1 could play a key role in the pathogenesis of thymoma associated myasthenia gravis (MG) by changing lymphocyte T expression.

A small proportion of patients with myasthenia gravis (MG) have alopecia and taste disorders, according to a new study published in the journal BMC Neurology. “Clinicians should be aware of the ...